Jingfeng Biological
Latest round
- Series A
Last raised
- Oct 2021
Total raised
- $10M
Investors
- 1
About Jingfeng Biological
Established in 2020 and based in Qingdao, China, Jingfeng Biological is a biological company that focuses on the research and development of tumor cell therapy products. Dr. Fuli Yu, the company’s founder and CEO, worked in the Human Genome Sequencing Center of the Department of Genetics of Baylor College of Medicine and served as the Chief Information Officer of Berry Gene. The company engages in the research and development of tumor cell therapy products. Its main products include neoantigen-driven TIL, single-cell multi-omics TIL scanning, and end-to-end CMC. The company's products are used in the treatment of tumor infiltrating lymphocytes (TIL).
Who invested in Jingfeng Biological
1 investor across 1 round
See all investors in Jingfeng Biological
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 11, 2021
Amount
$10M
Investors
Questions about Jingfeng Biological
Who invested in Jingfeng Biological?
Jingfeng Biological has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Jingfeng Biological raised?
Jingfeng Biological has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Jingfeng Biological last raise money?
Jingfeng Biological's most recent round on record is a Series A, in Oct 2021.
What does Jingfeng Biological do?
Established in 2020 and based in Qingdao, China, Jingfeng Biological is a biological company that focuses on the research and development of tumor cell therapy products.
Where is Jingfeng Biological headquartered?
Jingfeng Biological is headquartered in Qingdao, China.
Which VCs invest in companies like Jingfeng Biological?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Jingfeng Biological's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Jingfeng Biological? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.